On Feb. 20, the American College of Obstetrics and Gynecologists published its first clinical guidance on diagnosing endometriosis, a chronic inflammatory disorder that affects 1 in 10 women of reproductive age.
On average, patients wait four to 11 years after experiencing symptoms to receive a diagnosis, according to the ACOG. To reduce this diagnostic delay, the organization recommends a physical examination or assessment of symptoms to provide a presumptive diagnosis of endometriosis.
The guidance aims to shorten the diagnostic delay and prompt faster treatment.
“While patients are waiting for a diagnosis, they can experience disease progression, onset of new symptoms, further decline in quality of life and increasing healthcare costs,” the ACOG said in a news release. “The traditional reliance on surgical findings” — such as results from a pelvic laparoscopy — “to diagnose endometriosis is an important contributor to diagnostic delays.”
Diagnoses for the disorder increased 32% in recent years, from 24.9 diagnoses per 10,000 patients in 2017 to 32.8 in 2024, according to a study conducted by Epic Research.
Access the new guidance here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
